Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |